Abbott Laboratories Profit Jumps As All Business Units Shine

January 21, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

NEW YORK (Reuters) - Abbott Laboratories said on Wednesday fourth-quarter earnings jumped 28 percent on demand for its prescription drugs, nutritional products and medical devices, including its new Xience stent used to prop open coronary arteries.

Twitter
LinkedIn
Facebook
Email
Print

Earnings

Abbott Laboratories